A Study to Compare ETC vs. EC-TX and Ibandronate vs. Observation in Patients With Node-positive Primary Breast Cancer (GAIN)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Epirubicine|DRUG: Cyclophosphamide|DRUG: Taxol|DRUG: Xeloda|DRUG: Ibandronat
Sponsor: German Breast Group